Invivyd clinical trials we track

Check company identity source

Phase 3 3 trials

Phase 2 / 3 2 trials

TrialDrugs studiedStatusPrimary completion
Evaluation of ADG20 for the Prevention of COVID-19NCT04859517ADG20Terminated2022-11-04Actual
Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19NCT04805671ADG20, Normal salineTerminated2022-02-10Actual

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination SyndromeNCT07899346VYD2311Not yet recruiting2027-06Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Aug 2026. After: 15 Aug 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source